The Obesity ETF (SLIM)

Delayed Data
As of Feb 15
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the performance- before fees and expenses- of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese- including biotechnology- pharmaceutical- health care and medical device companies whose business is focused on obesity and obesity related disease and companies focused on weight loss programs- weight loss supplements- or plus sized apparel. The fund invests at least 80% of its net assets in the stocks that comprise the Solactive Obesity Index. It is non-diversified.


1 month+1.12% 3 years--
3 months+11.39% 5 years--
1 year+37.52% Since inception+16.16%
Data through 02/17/2018

Quote Details

Previous close$32.09
Open day’s range31.91 – 32.30
Net asset value (NAV)32.26 (02/16/2018)
Daily volume139
Average volume (3 months)1,837
Data as of 1:07pm ET, 02/15/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+17.28%
Expense Gross exp ratio0.50%1.31%
Risk 5 year sharpe ratio--1.11
Net assets$3.3M$3.2B
Average market cap$11.1B$9.5B
Average P/E24.722.6
Dividend / Share--0.34%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 21.27%
-- 19.88%
DVA Davita Inc5.44%
-- 5.16%
DXCM DexCom Inc5.14%
PODD Insulet Corp5.03%
-- 4.22%
HLF Herbalife Ltd4.19%
-- 3.20%
WTW Weight Watchers International Inc2.62%